Kiniksa Pharmaceuticals (KNSA)
(Delayed Data from NSDQ)
$17.88 USD
+0.27 (1.53%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $17.87 -0.01 (-0.06%) 6:38 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 7/23/24 |
---|---|
Current Quarter | -0.06 |
EPS Last Quarter | -0.25 |
Last EPS Surprise | -78.57% |
ABR | 1.00 |
Earnings ESP
|
-9.09% |
---|---|
Current Year | -0.04 |
Next Year | 0.38 |
EPS (TTM) | -0.43 |
P/E (F1) | 293.50 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 87.45M | 99.20M | 375.21M | 473.69M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 88.60M | 99.30M | 377.10M | 501.90M |
Low Estimate | 86.30M | 99.10M | 373.31M | 445.47M |
Year ago Sales | 71.47M | 67.05M | 270.26M | 375.21M |
Year over Year Growth Est. | 22.36% | 47.95% | 38.83% | 26.25% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.06 | 0.02 | -0.04 | 0.38 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | -0.06 | -0.02 | -0.32 | 0.24 |
High Estimate | -0.05 | 0.05 | 0.45 | 1.15 |
Low Estimate | -0.06 | -0.02 | -0.32 | -0.24 |
Year ago EPS | -0.02 | -0.20 | -0.34 | -0.04 |
Year over Year Growth Est. | -200.00% | 110.00% | 88.24% | 1,058.33% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 2 | 2 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 1 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.06 | 0.02 | -0.04 | 0.38 |
7 Days Ago | -0.11 | -0.07 | -0.06 | -0.45 |
30 Days Ago | -0.11 | -0.07 | -0.05 | -0.43 |
60 Days Ago | -0.15 | -0.11 | -0.11 | -0.18 |
90 Days Ago | -0.15 | -0.11 | -0.11 | -0.18 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.06 | -0.02 | 0.07 | 0.70 |
Zacks Consensus Estimate | -0.06 | 0.02 | -0.04 | 0.38 |
Earnings ESP | -9.09% | -233.33% | 262.50% | 81.31% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.25 | 0.04 | -0.20 | -0.02 | NA |
Estimate | -0.14 | -0.11 | -0.18 | -0.16 | NA |
Difference | -0.11 | 0.15 | -0.02 | 0.14 | 0.04 |
Surprise | -78.57% | 136.36% | -11.11% | 87.50% | 33.55% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more